广州柏赛罗药业有限公司
- Country
- Ownership
- -
- Established
- 1995-11-29
- Employees
- -
- Market Cap
- -
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
41
NMPA:41
Drug Approvals
Sulbactam Sodium for Injection
- Product Name
- 注射用舒巴坦钠
- Approval Number
- 国药准字H20084134
- Approval Date
- Sep 18, 2020
NMPA
Cefotaxime Sodium for Injection
- Product Name
- 注射用头孢噻肟钠
- Approval Number
- 国药准字H20023291
- Approval Date
- Sep 18, 2020
NMPA
Cefotaxime Sodium for Injection
- Product Name
- 注射用头孢噻肟钠
- Approval Number
- 国药准字H20023290
- Approval Date
- Sep 18, 2020
NMPA
Pentoxifylline Injection
- Product Name
- 己酮可可碱注射液
- Approval Number
- 国药准字H20043488
- Approval Date
- Sep 18, 2020
NMPA
Sulbactam Sodium for Injection
- Product Name
- 注射用舒巴坦钠
- Approval Number
- 国药准字H20084135
- Approval Date
- Sep 18, 2020
NMPA
Lidocaine Hydrochloride Injection
- Product Name
- 盐酸利多卡因注射液
- Approval Number
- 国药准字H20059035
- Approval Date
- Sep 18, 2020
NMPA
Ceftriaxone Sodium for Injection
- Product Name
- 注射用头孢曲松钠
- Approval Number
- 国药准字H20033230
- Approval Date
- Sep 18, 2020
NMPA
Sterile Water for Injection
- Product Name
- 灭菌注射用水
- Approval Number
- 国药准字H20043018
- Approval Date
- Sep 18, 2020
NMPA
Ceftazidime for Injection
- Product Name
- 注射用头孢他啶
- Approval Number
- 国药准字H20043549
- Approval Date
- Sep 18, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
Clinical Trials
No trials found
News
No news found